Skip to main content
Log in

The in vitro cross-effects of inhibitors of renin-angiotensin and fibrinolytic systems on the key enzymes of these systems

  • Review Articles
  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

The effects of hypotensive agents (captopril, enalaprilat, and lisinopril) on the activities of components of the fibrinolytic system (FS) and the effects of antifibrinolytic agents (6-aminohexanoic acid (6-AHA) and tranexamic acid (t-AMCHA)) on the activities of angiotensin converting enzyme (ACE) were studied in vitro. Enalaprilat did not affect the FS activity. Captopril considerably inhibited the amidase activities of urokinase (u-PA), tissue plasminogen activator (t-PA), and plasmin ([I]50 (2.0−2.6) ± 0.1 mM), and the activation of Glu-plasminogen by t-PA and u-PA ([I]50 (1.50−1.80) ± 0.06 mM), which may be due to the presence of a mercapto group in the inhibitor molecule. Lisinopril did not affect the amidase activities of FS enzymes, but stimulated Glu-plasminogen activation by u-PA and inhibited activation fibrin-bound Glu-plasminogen by t-PA ([I]50 (12.0 ± 0.5) mM). Presumably, these effects can be explained by the presence in lisinopril of a Lys side residue, whose binding to lysine-binding Glu-plasminogen centers resulted, on the one hand, in the transformation from its closed conformation to a semi-open one and, on the other hand, in its desorption from fibrin. Unspecific inhibition of the activity of ACE, a key enzyme of the renin-angiotensin system, in the presence of 6-AHA and t-AMCHA ([I]50 10.0 ± 0.5 and 7.5 ± 0.4 mM, respectively) was found. A decrease in the ACE activity along with the growth of the fibrin monomer concentration was revealed. The data demonstrate that, along with endogenous mediated interaction between FS and RAS, relations based on the direct interactions of exogenous inhibitors of one system affecting the activities of components of another system can take place.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACE:

angiotensin-converting enzyme

6-AHA, AFK-pNA:

INI-Ala-Phe-Lys p-nitroanilide; 6-aminohexanoic acid

t-AMCHA:

trans-(4-aminomethyl)cyclohexanecarboxylic (or tranexamic) acid

FS:

fibrinolytic system

RAS:

renin-angiotensin system

Glu-Pg:

native plasminogen Glu form

LBS:

lysine-binding sites

t-PA:

tissue plasminogen activator

u-PA:

double-stranded urokinase

PAI-1:

type 1 plasminogen activator inhibitor

References

  1. Saksela, O. and Rifkin, D.B., Annu. Rev. Cell Biol., 1988, vol. 4, pp. 493–526.

    Article  Google Scholar 

  2. Collen, D. and Lijnen, H.R., Blood, 1991, vol. 78, pp. 3114–3124.

    PubMed  CAS  Google Scholar 

  3. Lijnen, H.R., Ann. N.Y. Acad. Sci., 2001, vol. 936, pp. 226–236.

    Article  PubMed  CAS  Google Scholar 

  4. Ghosh, S., Ellerbroek, S.M., Wu, Y., and Stack, M.S., Fibrinolysis, 2000, vol. 14, pp. 87–97.

    CAS  Google Scholar 

  5. Booth, N.A., Fibrinol. Proteol., 2000, vol. 14, pp. 206–213.

    Article  CAS  Google Scholar 

  6. Huckle, W.R. and Earp, H.S., Prog. Growth Factor Res., 1994, vol. 5, pp. 177–194.

    Article  PubMed  CAS  Google Scholar 

  7. Escobar, E., Rodriguez-Reyna, T.S., Arrieta, O., and Sotelo, J., Curr. Vasc. Pharmacol., 2004, vol. 2, pp. 385–399.

    Article  PubMed  CAS  Google Scholar 

  8. Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., and Egido, J., Int. J. Biochem. Cell Biol., 2003, vol. 35, pp. 881–900.

    Article  PubMed  CAS  Google Scholar 

  9. Mombouli, J.V., Illiano, S., Nagao, T., Scott-Burden, T., and Vanhautte, P.M., Circ. Res., 1992, vol. 8, pp. 137–144.

    Google Scholar 

  10. Brown, N.J., Agirbasli, M.A., Williams, G.H., Litchfield, W.R., and Vaughan, D.E., Hypertension, 1998, vol. 32, pp. 965–971.

    PubMed  CAS  Google Scholar 

  11. Mogielnicki, A., Chabielska, E., Pawlak, R., Szemraj, J., and Buczko, W., Thromb. Haemost., 2005, vol. 93, pp. 1069–1076.

    PubMed  CAS  Google Scholar 

  12. Brown, N.J., Gainer, J.V., Murphey, L.J., and Vaughan, D.E., Circulation, 2000, vol. 102, pp. 2190–2196.

    PubMed  CAS  Google Scholar 

  13. Hasan, A.A., Amenta, S., and Schmaier, A.H., Circulation, 1996, vol. 94, pp. 517–528.

    PubMed  CAS  Google Scholar 

  14. Pretorius, M., Rosenbaum, D.A., Vaughan, D.E., and Brown, N.J., Circulation, 2003, vol. 107, pp. 579–585.

    Article  PubMed  Google Scholar 

  15. Yusuf, S. and Lonn, E., Eur. Heart. J., 1998, vol. 19, Suppl. J, pp. J36–J44.

    Article  PubMed  CAS  Google Scholar 

  16. Oshima, S., Ogawa, H., Mizuno, Y., Yamashita, S., Noda, K., Saito, T., Sumida, H., Suefuji, H., Kaikita, K., Soejima, H., and Yasue, H., Am. Heart J., 1997, vol. 34, pp. 961–966.

    Article  Google Scholar 

  17. Ferres, H., Drugs, 1987, vol. 33,Suppl. 3, pp. 33–50.

    Article  PubMed  CAS  Google Scholar 

  18. Entsiklopediya lekarstv (Drug Encyclopedia), Krylov, Yu.F., Ed., Moscow: RLS-2001, 2001.

    Google Scholar 

  19. Kost, O.A., Chesnokova, N.B., Makarov, P.V., Nikol’skaya, I.I., Kazanskaya, N.F., Beznos, O.B., and Binevskii, P.V., RF Patent 2 277 411, Byull. Izobret., 2006, No. 16.

  20. Ponting, C.P., Marshall, J.M., and Cederholm-Williams, S.A., Blood Coagul. Fibrinolysis, 1992, vol. 3, pp. 605–614.

    Article  PubMed  CAS  Google Scholar 

  21. Marshall, J.M., Brown, A.J., and Pointing, C.P., Biochemistry, 1994, vol. 33, pp. 3599–3606.

    Article  PubMed  CAS  Google Scholar 

  22. Marcus, G., De Pascuale, J.L., and Wissler, F.C., J. Biol. Chem., 1978, vol. 253, pp. 727–732.

    Google Scholar 

  23. Wiman, B., Lijnen, H.R., and Collen, D., Biochim. Biophys. Acta, 1979, vol. 579, pp. 142–154.

    PubMed  CAS  Google Scholar 

  24. Collen, D., Thromb. Haemost., 1999, vol. 82, pp. 259–270.

    PubMed  CAS  Google Scholar 

  25. Markus, G., Fibrinolysis, 1996, vol. 10, pp. 75–85.

    Article  CAS  Google Scholar 

  26. Urano, T., de Serrano, V.S., Chiber, B.A.K., and Castellino, F.J., J. Biol. Chem., 1987, vol. 262, pp. 15959–15964.

    PubMed  CAS  Google Scholar 

  27. Thorsen, S. and Mullertz, S., Scand. J. Lab. Invest, 1974, vol. 34, pp. 167–176.

    Article  CAS  Google Scholar 

  28. Urano, T., de Serrano, V.S., Chiber, B.A.K., and Castellino, F.J., Biochemistry, 1988, vol. 27, pp. 6522–6528.

    Article  PubMed  CAS  Google Scholar 

  29. Moalli, R., Saldeen, K., and Saldeen, T., J. Pharmacol. Exp. Ther., 1987, vol. 243, pp. 897–900.

    PubMed  CAS  Google Scholar 

  30. Aisina, R., Mukhametova, L., Gershkovich, K., and Varfolomeyev, S.D., Biochim. Biophys. Acta, 2005, vol. 1725, pp. 370–376.

    PubMed  CAS  Google Scholar 

  31. Kost, O.A., Bovin, N.V., Chemodanova, E.E., Nasonov, V.V., and Ort, T.A., J. Mol. Recog., 2000, vol. 13, pp. 360–369.

    Article  CAS  Google Scholar 

  32. Lowry, U.K., Rosenbrough, N.J., Farr, A.L., and Bandall, K.L., J. Biol. Chem., 1951, vol. 193, pp. 265–271.

    PubMed  CAS  Google Scholar 

  33. Laemmly, U.K., Nature, 1970, vol. 227, pp. 680–685.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. B. Aisina.

Additional information

Original Russian Text © L.I. Mukhametova, D.A. Gulin, P.V. Binevski, R.B. Aisina, O.A. Kost, I.I. Nikolskaya, 2008, published in Bioorganicheskaya Khimiya, 2008, Vol. 34, No. 4, pp. 471–478.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukhametova, L.I., Gulin, D.A., Binevski, P.V. et al. The in vitro cross-effects of inhibitors of renin-angiotensin and fibrinolytic systems on the key enzymes of these systems. Russ J Bioorg Chem 34, 421–427 (2008). https://doi.org/10.1134/S1068162008040055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162008040055

Key words

Navigation